CytoSorbents Announces HotSwap(TM) Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

Stock Information for Borqs Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Borqs Technologies Inc.

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.